Successful Application of Tocilizumab in a Patient With Neoadjuvant Immunochemotherapy-Induced Cytokine Release Syndrome.
Soichiro MinamiYosuke KawashimaYasuhiko MunakataMasahiro MatsunoShuichiro HaraYusuke YamazakiTsuyoshi DomanShin SaitoTetsuo OdakaTakahiro OgasawaraHisashi ShimizuJun SugisakaTomoiki AibaYukihiro ToiShinsuke YamandaYuichiro KimuraShunichi SugawaraPublished in: Cancer reports (Hoboken, N.J.) (2024)
This indicates the potential effectiveness of early tocilizumab administration for ICI-induced CRS, even in mild cases.
Keyphrases
- squamous cell carcinoma
- locally advanced
- rheumatoid arthritis
- high glucose
- diabetic rats
- case report
- juvenile idiopathic arthritis
- systematic review
- rectal cancer
- drug induced
- lymph node
- rheumatoid arthritis patients
- endothelial cells
- oxidative stress
- diffuse large b cell lymphoma
- systemic lupus erythematosus
- risk assessment
- radiation therapy
- climate change